Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0000950170-24-070797

Options or other derivatives

  • Director acquired 5,753 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Zeiher Bernhardt G Director 2024-06-06 Grant or award · Stock Option (right to buy) +5,753 5,753 D
Loading xslF345X05/ownership.xml…